MATTHEW GRAVETT: Open Payments
NPI 1750681516 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 64 payments from 16 companies in 2025. Trend: 2023 $513 · 2024 $908 · 2025 $1,209
Food & beverage: $1,209
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $245 |
| Amgen Inc. | 14 | $189 |
| Novo Nordisk Inc | 12 | $170 |
| ViiV Healthcare Company | 1 | $125 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $59 |
| Abbott Laboratories | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| ABBVIE INC. | 2 | $46 |
| SANOFI PASTEUR INC. | 2 | $41 |
Products named: AIRSUPRA, Rybelsus, ROTATEQ, OTEZLA, EVENITY, Ozempic, Kerendia, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
